Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review
Authors:
Open Access
- 6 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1-12
Abstract
About 5–10% of neurofibromatosis type 1 (NF1) patients exhibit large genomic germline deletions that remove the NF1 gene and its flanking regions. The most frequent NF1 large deletion is 1.4 Mb, resulting from homologous recombination between two low copy repeats. This “type-1” deletion is associated with a severe clinical phenotype in NF1 patients, with several phenotypic manifestations including learning disability, a much earlier development of cutaneous neurofibromas, an increased tumour risk, and cardiovascular malformations. NF1 adjacent co-deleted genes could act as modifier loci for the specific clinical manifestations observed in deleted NF1 patients. Furthermore, other genetic modifiers (such as CNVs) not located at the NF1 locus could also modulate the phenotype observed in patients with large deletions. In this study, we analysed 22 NF1 deletion patients by genome-wide array-CGH with the aim (1) to correlate deletion length to observed phenotypic features and their severity in NF1 deletion syndrome, and (2) to identify whether the deletion phenotype could also be modulated by copy number variations elsewhere in the genome. We then review the role of co-deleted genes in the 1.4 Mb interval of type-1 deletions, and their possible implication in the main clinical features observed in this high-risk group of NF1 patients.Keywords
This publication has 76 references indexed in Scilit:
- EED and EZH2 constitutive variants: A study to expand the Cohen‐Gibson syndrome phenotype and contrast it with Weaver syndromeAmerican Journal of Medical Genetics Part A, 2019
- Confirmation of mutation landscape of NF1‐associated malignant peripheral nerve sheath tumorsGenes, Chromosomes and Cancer, 2017
- The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cellsCancer Medicine, 2016
- Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletionsHuman Mutation, 2010
- NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotypeHuman Mutation, 2010
- Acute lymphoblastic leukemia in Weaver syndromeAmerican Journal of Medical Genetics Part A, 2010
- Neurofibromatosis type 1 is a disorder of dysplasia: The importance of distinguishing features, consequences, and complicationsBirth Defects Research Part A: Clinical and Molecular Teratology, 2009
- RNF135mutations are not present in patients with Sotos syndrome‐like featuresAmerican Journal of Medical Genetics Part A, 2009
- Intelligence in individuals with a neurofibromatosis type 1 microdeletionAmerican Journal of Medical Genetics Part A, 2004
- Cervical spine anomalies and tumors in Weaver syndromeAmerican Journal of Medical Genetics, 2000